Our share price analysis, data and how-to-buy guides cover significant market movements in the most popular UK shares in the FTSE 100, US stocks in the DJIA, commodities, indices, and currency pairs. They are designed to help you make more informed decisions about what to invest in, what to trade, and when to execute currency transactions.
Down 80%, are Impax Asset Management (IPX) shares a top buy for 2025?
Shares in British asset manager Impax Asset Management (IPX:LON) have tanked recently, falling more than 80% from their highs. As a result, they now sport a low valuation and a high dividend yield. Is there an opportunity here for savvy investors? Let’s take a look. What does Impax Asset Management do? Impax Asset Management is
Best UK healthcare/pharmaceutical stocks for 2025
Healthcare is a sector with immense long-term growth potential. Over the next decade, demand for healthcare solutions is projected to rise significantly as the global population ages and the prevalence of chronic diseases increases. When it comes to healthcare stocks, UK investors have many options, ranging from FTSE 100 pharma giants to small companies listed
Sterling outperforms in 2024; however, downside is a risk for 2025
While 2023 was a year for raising rates, the main theme that markets were focussed on in 2024, was when rate cuts would begin, with some suggesting that the Fed could start reversing course in March of this year, with the Bank of England following soon after. This came across as optimistic and mispriced in
Winners and losers of 2024, as the FTSE100 underperforms again
For the FTSE 100 it’s been yet another year of underperformance, barely eking out a gain in 2023, at least this year we’ve seen the UK benchmark index break above the 8,000 level and achieve a new record high in the first half of the year. The performance since that record high has been symptomatic
Croda has had a rocky 2024, but Hargreaves Lansdown thinks 2025 will be better.
The speciality chemicals group Croda (CRDA) is something of a last man standing in the UK-listed companies in the sector. The company was founded in 1925 and today has a market cap of £4.90 billion and just over 6000 employees. The current business is much different to the one founded almost a century ago, and
Airbus share price takes off but can it continue flying for 2025?
One of two companies that make wide-bodied jets on global scale (the other being Boeing). Airbus is a genuine European champion. Issues around corporate governance, safety and quality control, and more recently industrial action at its major rival, have provided Airbus with the runway to take a lead over its US peer. However, as we
